de Bock GH - Search Results

1

Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.

Stroot IAS, Bart J, Hollema H, Jalving M, Wagner MM, Yigit R, van Doorn HC, de Hullu JA, Gaarenstroom KN, van Beurden M, van Lonkhuijzen LRCW, Slangen BFM, Zweemer RP, Gómez García EB, Ausems MGEM, Boere IA, van Hest LP, Duijkers FAM, van Asperen CJ, Schmidt MK, Wevers MR, Ruijs MWG, Devilee P, Collée JM, Hebon Investigators, de Bock GH, Mourits MJE. Stroot IAS, et al. Among authors: de bock gh, de hullu ja. Gynecol Oncol. 2024 Aug;187:198-203. doi: 10.1016/j.ygyno.2024.05.024. Epub 2024 May 24. Gynecol Oncol. 2024. PMID: 38795508 Free article.

2

Prevalence of BRCA1 in a hospital-based population of Dutch breast cancer patients.

Papelard H, de Bock GH, van Eijk R, Vliet Vlieland TP, Cornelisse CJ, Devilee P, Tollenaar RA. Papelard H, et al. Among authors: de bock gh. Br J Cancer. 2000 Sep;83(6):719-24. doi: 10.1054/bjoc.2000.1331. Br J Cancer. 2000. PMID: 10952774 Free PMC article.

3

Clinical and pathological features of BRCA1 associated carcinomas in a hospital-based sample of Dutch breast cancer patients.

de Bock GH, Tollenaar RA, Papelard H, Cornelisse CJ, Devilee P, van de Vijver MJ. de Bock GH, et al. Br J Cancer. 2001 Nov 2;85(9):1347-50. doi: 10.1054/bjoc.2001.2103. Br J Cancer. 2001. PMID: 11720473 Free PMC article.

4

Possible consequences of applying guidelines to healthy women with a family history of breast cancer.

van Asperen CJ, Tollenaar RA, Krol-Warmerdam EM, Blom J, Hoogendoorn WE, Seynaeve CM, Brekelmans CT, Devilee P, Cornelisse CJ, Klijn JG, de Bock GH. van Asperen CJ, et al. Among authors: de bock gh. Eur J Hum Genet. 2003 Aug;11(8):633-6. doi: 10.1038/sj.ejhg.5201021. Eur J Hum Genet. 2003. PMID: 12891386

5

Risk estimation for healthy women from breast cancer families: new insights and new strategies.

van Asperen CJ, Jonker MA, Jacobi CE, van Diemen-Homan JE, Bakker E, Breuning MH, van Houwelingen JC, de Bock GH. van Asperen CJ, et al. Among authors: de bock gh. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):87-93. doi: 10.1158/1055-9965.epi-03-0090. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744738

6

Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variant.

de Bock GH, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG. de Bock GH, et al. J Med Genet. 2004 Oct;41(10):731-5. doi: 10.1136/jmg.2004.019737. J Med Genet. 2004. PMID: 15466005 Free PMC article.

7

Patterns and frequency of recurrences of squamous cell carcinoma of the vulva.

Woolderink JM, de Bock GH, de Hullu JA, Davy MJ, van der Zee AG, Mourits MJ. Woolderink JM, et al. Among authors: de bock gh, de hullu ja. Gynecol Oncol. 2006 Oct;103(1):293-9. doi: 10.1016/j.ygyno.2006.03.010. Epub 2006 May 2. Gynecol Oncol. 2006. PMID: 16631238 Free article.

8

EGFR expression is associated with groin node metastases in vulvar cancer, but does not improve their prediction.

Oonk MH, de Bock GH, van der Veen DJ, Ten Hoor KA, de Hullu JA, Hollema H, van der Zee AG. Oonk MH, et al. Among authors: de bock gh, de hullu ja. Gynecol Oncol. 2007 Jan;104(1):109-13. doi: 10.1016/j.ygyno.2006.07.035. Epub 2006 Sep 11. Gynecol Oncol. 2007. PMID: 16963112 Free article.

9

Exogenous steroids for menopausal symptoms and breast/endometrial cancer risk.

Mourits MJ, DE Bock GH. Mourits MJ, et al. Among authors: de bock gh. Int J Gynecol Cancer. 2006;16 Suppl 2:494-6. doi: 10.1111/j.1525-1438.2006.00677.x. Int J Gynecol Cancer. 2006. PMID: 17010054

10

Association between the CHEK2*1100delC germ line mutation and estrogen receptor status.

de Bock GH, Mourits MJ, Schutte M, Krol-Warmerdam EM, Seynaeve C, Blom J, Brekelmans CT, Meijers-Heijboer H, van Asperen CJ, Cornelisse CJ, Devilee P, Tollenaar RA, Klijn JG. de Bock GH, et al. Int J Gynecol Cancer. 2006;16 Suppl 2:552-5. doi: 10.1111/j.1525-1438.2006.00694.x. Int J Gynecol Cancer. 2006. PMID: 17010071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

591 results

Search Page

Filters